UA81215C2

UA81215C2 - Method of prevention and treatment of amyloid-induced diseases

Method of prevention and treatment of amyloid-induced diseases Download PDF

Info

Publication number: UA81215C2
Authority: UA; Ukraine
Prior art keywords: antibody; disease; patient; peptide; differs
Prior art date: 1999-05-28

Application number

UA2001118146A

Other languages

English (en)

Ukrainian (uk)

Priority date

1999-05-28

Filing date

2000-05-26

Publication date

2007-12-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23254226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81215(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-05-26 Application filed filed Critical

2007-12-25 Publication of UA81215C2 publication Critical patent/UA81215C2/uk

Links

238000000034 method Methods 0.000 title claims abstract description 250
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 77
201000010099 disease Diseases 0.000 title claims abstract description 75
238000011282 treatment Methods 0.000 title claims abstract description 74
230000002265 prevention Effects 0.000 title claims abstract description 14
210000004556 brain Anatomy 0.000 claims abstract description 103
208000024827 Alzheimer disease Diseases 0.000 claims abstract description 68
230000009851 immunogenic response Effects 0.000 claims abstract description 16
108090000765 processed proteins & peptides Proteins 0.000 claims description 332
239000002671 adjuvant Substances 0.000 claims description 133
102000004196 processed proteins & peptides Human genes 0.000 claims description 116
210000004027 cell Anatomy 0.000 claims description 95
101710137189 Amyloid-beta A4 protein Proteins 0.000 claims description 83
101710151993 Amyloid-beta precursor protein Proteins 0.000 claims description 83
102100022704 Amyloid-beta precursor protein Human genes 0.000 claims description 83
DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 claims description 82
150000001413 amino acids Chemical group 0.000 claims description 79
208000037259 Amyloid Plaque Diseases 0.000 claims description 72
230000028993 immune response Effects 0.000 claims description 58
238000009739 binding Methods 0.000 claims description 56
229920001184 polypeptide Polymers 0.000 claims description 56
230000027455 binding Effects 0.000 claims description 55
239000003795 chemical substances by application Substances 0.000 claims description 52
238000006243 chemical reaction Methods 0.000 claims description 51
239000000203 mixture Substances 0.000 claims description 43
230000000694 effects Effects 0.000 claims description 42
210000001744 T-lymphocyte Anatomy 0.000 claims description 30
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 27
230000008105 immune reaction Effects 0.000 claims description 26
210000004369 blood Anatomy 0.000 claims description 24
239000008280 blood Substances 0.000 claims description 24
210000003719 b-lymphocyte Anatomy 0.000 claims description 20
208000010877 cognitive disease Diseases 0.000 claims description 15
238000012216 screening Methods 0.000 claims description 15
208000024891 symptom Diseases 0.000 claims description 15
206010057249 Phagocytosis Diseases 0.000 claims description 14
230000002025 microglial effect Effects 0.000 claims description 14
230000008782 phagocytosis Effects 0.000 claims description 14
239000008194 pharmaceutical composition Substances 0.000 claims description 13
230000001404 mediated effect Effects 0.000 claims description 12
108091033319 polynucleotide Proteins 0.000 claims description 12
102000040430 polynucleotide Human genes 0.000 claims description 12
239000002157 polynucleotide Substances 0.000 claims description 12
230000009870 specific binding Effects 0.000 claims description 12
201000010374 Down Syndrome Diseases 0.000 claims description 10
210000004899 c-terminal region Anatomy 0.000 claims description 10
238000012544 monitoring process Methods 0.000 claims description 9
230000037396 body weight Effects 0.000 claims description 6
125000001433 C-terminal amino-acid group Chemical group 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 4
239000003937 drug carrier Substances 0.000 claims description 4
230000036647 reaction Effects 0.000 claims description 4
238000013268 sustained release Methods 0.000 claims description 2
239000012730 sustained-release form Substances 0.000 claims description 2
101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims 1
102000012427 human indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims 1
241001465754 Metazoa Species 0.000 description 193
230000003053 immunization Effects 0.000 description 141
238000002649 immunization Methods 0.000 description 141
241000699670 Mus sp. Species 0.000 description 136
230000002163 immunogen Effects 0.000 description 83
229940024606 amino acid Drugs 0.000 description 79
235000001014 amino acid Nutrition 0.000 description 76
239000012634 fragment Substances 0.000 description 73
238000002347 injection Methods 0.000 description 69
239000007924 injection Substances 0.000 description 69
238000004458 analytical method Methods 0.000 description 66
239000000427 antigen Substances 0.000 description 66
108091007433 antigens Proteins 0.000 description 66
102000036639 antigens Human genes 0.000 description 66
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 59
239000002953 phosphate buffered saline Substances 0.000 description 53
239000003814 drug Substances 0.000 description 52
210000001519 tissue Anatomy 0.000 description 52
239000000243 solution Substances 0.000 description 45
238000002360 preparation method Methods 0.000 description 44
241000699666 Mus <mouse, genus> Species 0.000 description 42
230000007423 decrease Effects 0.000 description 42
108090000623 proteins and genes Proteins 0.000 description 41
210000002966 serum Anatomy 0.000 description 40
108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 38
210000003710 cerebral cortex Anatomy 0.000 description 35
210000001320 hippocampus Anatomy 0.000 description 34
238000002595 magnetic resonance imaging Methods 0.000 description 33
235000018102 proteins Nutrition 0.000 description 33
102000004169 proteins and genes Human genes 0.000 description 33
230000001225 therapeutic effect Effects 0.000 description 33
229940079593 drug Drugs 0.000 description 31
230000001054 cortical effect Effects 0.000 description 29
230000004044 response Effects 0.000 description 29
239000000306 component Substances 0.000 description 27
238000002474 experimental method Methods 0.000 description 26
238000005259 measurement Methods 0.000 description 26
230000002829 reductive effect Effects 0.000 description 26
239000000523 sample Substances 0.000 description 25
238000012360 testing method Methods 0.000 description 25
230000001965 increasing effect Effects 0.000 description 23
108060003951 Immunoglobulin Proteins 0.000 description 22
108020001507 fusion proteins Proteins 0.000 description 22
102000037865 fusion proteins Human genes 0.000 description 22
102000018358 immunoglobulin Human genes 0.000 description 22
239000000126 substance Substances 0.000 description 22
238000003556 assay Methods 0.000 description 20
239000000562 conjugate Substances 0.000 description 20
239000000463 material Substances 0.000 description 20
238000010171 animal model Methods 0.000 description 19
238000011160 research Methods 0.000 description 18
229940124597 therapeutic agent Drugs 0.000 description 17
239000003153 chemical reaction reagent Substances 0.000 description 16
238000011161 development Methods 0.000 description 16
230000018109 developmental process Effects 0.000 description 16
239000000725 suspension Substances 0.000 description 16
239000013598 vector Substances 0.000 description 16
108010048112 Amyloidogenic Proteins Proteins 0.000 description 15
102000009091 Amyloidogenic Proteins Human genes 0.000 description 15
239000007790 solid phase Substances 0.000 description 15
239000003826 tablet Substances 0.000 description 15
230000009261 transgenic effect Effects 0.000 description 15
238000011830 transgenic mouse model Methods 0.000 description 15
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 14
241000283973 Oryctolagus cuniculus Species 0.000 description 14
239000000969 carrier Substances 0.000 description 14
239000003085 diluting agent Substances 0.000 description 14
230000035772 mutation Effects 0.000 description 14
241000699660 Mus musculus Species 0.000 description 13
210000001638 cerebellum Anatomy 0.000 description 13
230000000971 hippocampal effect Effects 0.000 description 13
239000002609 medium Substances 0.000 description 13
241000282693 Cercopithecidae Species 0.000 description 12
108020004414 DNA Proteins 0.000 description 12
108700018351 Major Histocompatibility Complex Proteins 0.000 description 12
230000003942 amyloidogenic effect Effects 0.000 description 12
230000001939 inductive effect Effects 0.000 description 12
210000002241 neurite Anatomy 0.000 description 12
238000012545 processing Methods 0.000 description 12
230000009257 reactivity Effects 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
241000700605 Viruses Species 0.000 description 11
150000001875 compounds Chemical class 0.000 description 11
230000000069 prophylactic effect Effects 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 10
239000000872 buffer Substances 0.000 description 10
238000001514 detection method Methods 0.000 description 10
238000010191 image analysis Methods 0.000 description 10
238000004519 manufacturing process Methods 0.000 description 10
230000007170 pathology Effects 0.000 description 10
230000009467 reduction Effects 0.000 description 10
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 10
206010018341 Gliosis Diseases 0.000 description 9
241001494479 Pecora Species 0.000 description 9
108010055044 Tetanus Toxin Proteins 0.000 description 9
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
125000003275 alpha amino acid group Chemical group 0.000 description 9
210000001130 astrocyte Anatomy 0.000 description 9
230000003247 decreasing effect Effects 0.000 description 9
238000012217 deletion Methods 0.000 description 9
230000037430 deletion Effects 0.000 description 9
239000000839 emulsion Substances 0.000 description 9
238000005755 formation reaction Methods 0.000 description 9
230000008569 process Effects 0.000 description 9
229940031439 squalene Drugs 0.000 description 9
238000006467 substitution reaction Methods 0.000 description 9
229940118376 tetanus toxin Drugs 0.000 description 9
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 8
-1 G-carboxyglutamate Chemical compound 0.000 description 8
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
241000124008 Mammalia Species 0.000 description 8
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 8
239000007853 buffer solution Substances 0.000 description 8
238000005119 centrifugation Methods 0.000 description 8
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
230000004927 fusion Effects 0.000 description 8
239000013642 negative control Substances 0.000 description 8
210000001539 phagocyte Anatomy 0.000 description 8
238000004445 quantitative analysis Methods 0.000 description 8
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 8
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 8
229940033663 thimerosal Drugs 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
241000700198 Cavia Species 0.000 description 7
238000002965 ELISA Methods 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
241000282412 Homo Species 0.000 description 7
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 7
241000700159 Rattus Species 0.000 description 7
210000005013 brain tissue Anatomy 0.000 description 7
238000004422 calculation algorithm Methods 0.000 description 7
230000008859 change Effects 0.000 description 7
230000000875 corresponding effect Effects 0.000 description 7
230000001419 dependent effect Effects 0.000 description 7
238000010790 dilution Methods 0.000 description 7
239000012895 dilution Substances 0.000 description 7
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 7
238000009826 distribution Methods 0.000 description 7
210000001353 entorhinal cortex Anatomy 0.000 description 7
210000004698 lymphocyte Anatomy 0.000 description 7
239000008176 lyophilized powder Substances 0.000 description 7
210000001616 monocyte Anatomy 0.000 description 7
108020004707 nucleic acids Proteins 0.000 description 7
102000039446 nucleic acids Human genes 0.000 description 7
150000007523 nucleic acids Chemical class 0.000 description 7
239000000863 peptide conjugate Substances 0.000 description 7
238000002823 phage display Methods 0.000 description 7
102000004127 Cytokines Human genes 0.000 description 6
108090000695 Cytokines Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
241000283073 Equus caballus Species 0.000 description 6
108700005091 Immunoglobulin Genes Proteins 0.000 description 6
241000283984 Rodentia Species 0.000 description 6
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
230000003941 amyloidogenesis Effects 0.000 description 6
208000037875 astrocytosis Diseases 0.000 description 6
230000007341 astrogliosis Effects 0.000 description 6
239000005018 casein Substances 0.000 description 6
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
235000021240 caseins Nutrition 0.000 description 6
239000002158 endotoxin Substances 0.000 description 6
244000144993 groups of animals Species 0.000 description 6
238000002991 immunohistochemical analysis Methods 0.000 description 6
210000000274 microglia Anatomy 0.000 description 6
230000001575 pathological effect Effects 0.000 description 6
239000013641 positive control Substances 0.000 description 6
238000003259 recombinant expression Methods 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
239000004472 Lysine Substances 0.000 description 5
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
241001529936 Murinae Species 0.000 description 5
102000019355 Synuclein Human genes 0.000 description 5
108050006783 Synuclein Proteins 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
235000003704 aspartic acid Nutrition 0.000 description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 5
239000012620 biological material Substances 0.000 description 5
230000008499 blood brain barrier function Effects 0.000 description 5
210000001218 blood-brain barrier Anatomy 0.000 description 5
230000002490 cerebral effect Effects 0.000 description 5
238000003018 immunoassay Methods 0.000 description 5
229940072221 immunoglobulins Drugs 0.000 description 5
238000011534 incubation Methods 0.000 description 5
238000002372 labelling Methods 0.000 description 5
239000003921 oil Substances 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
239000000902 placebo Substances 0.000 description 5
229940068196 placebo Drugs 0.000 description 5
210000002381 plasma Anatomy 0.000 description 5
102000005962 receptors Human genes 0.000 description 5
108020003175 receptors Proteins 0.000 description 5
239000001488 sodium phosphate Substances 0.000 description 5
229910000162 sodium phosphate Inorganic materials 0.000 description 5
238000010186 staining Methods 0.000 description 5
239000007858 starting material Substances 0.000 description 5
238000011269 treatment regimen Methods 0.000 description 5
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 5
HONKEGXLWUDTCF-YFKPBYRVSA-N (2s)-2-amino-2-methyl-4-phosphonobutanoic acid Chemical compound OC(=O)[C@](N)(C)CCP(O)(O)=O HONKEGXLWUDTCF-YFKPBYRVSA-N 0.000 description 4
241000283707 Capra Species 0.000 description 4
102000014914 Carrier Proteins Human genes 0.000 description 4
108010078791 Carrier Proteins Proteins 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
101000823051 Homo sapiens Amyloid-beta precursor protein Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
208000026139 Memory disease Diseases 0.000 description 4
102100021794 Microtubule-associated protein 4 Human genes 0.000 description 4
SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
108700019146 Transgenes Proteins 0.000 description 4
230000002159 abnormal effect Effects 0.000 description 4
230000004913 activation Effects 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 4
229940024545 aluminum hydroxide Drugs 0.000 description 4
238000013459 approach Methods 0.000 description 4
229940098773 bovine serum albumin Drugs 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
210000001175 cerebrospinal fluid Anatomy 0.000 description 4
238000004140 cleaning Methods 0.000 description 4
230000002860 competitive effect Effects 0.000 description 4
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 4
239000008367 deionised water Substances 0.000 description 4
229910021641 deionized water Inorganic materials 0.000 description 4
238000003745 diagnosis Methods 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
210000002443 helper t lymphocyte Anatomy 0.000 description 4
230000006872 improvement Effects 0.000 description 4
238000001802 infusion Methods 0.000 description 4
238000007917 intracranial administration Methods 0.000 description 4
239000002502 liposome Substances 0.000 description 4
239000007788 liquid Substances 0.000 description 4
210000002540 macrophage Anatomy 0.000 description 4
238000013507 mapping Methods 0.000 description 4
229940035032 monophosphoryl lipid a Drugs 0.000 description 4
230000001537 neural effect Effects 0.000 description 4
239000007764 o/w emulsion Substances 0.000 description 4
230000003287 optical effect Effects 0.000 description 4
239000002245 particle Substances 0.000 description 4
230000003449 preventive effect Effects 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
230000002441 reversible effect Effects 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
210000000952 spleen Anatomy 0.000 description 4
210000004989 spleen cell Anatomy 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 4
238000012546 transfer Methods 0.000 description 4
238000001262 western blot Methods 0.000 description 4
MFRCZYUUKMFJQJ-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1COC(=O)CO1 MFRCZYUUKMFJQJ-UHFFFAOYSA-N 0.000 description 3
208000000044 Amnesia Diseases 0.000 description 3
108090001008 Avidin Proteins 0.000 description 3
208000028698 Cognitive impairment Diseases 0.000 description 3
244000019459 Cynara cardunculus Species 0.000 description 3
235000019106 Cynara scolymus Nutrition 0.000 description 3
238000009007 Diagnostic Kit Methods 0.000 description 3
101100289989 Drosophila melanogaster alpha-Man-Ia gene Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 3
101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 3
101000616438 Homo sapiens Microtubule-associated protein 4 Proteins 0.000 description 3
108010001336 Horseradish Peroxidase Proteins 0.000 description 3
102100022338 Integrin alpha-M Human genes 0.000 description 3
101150021286 MAS1 gene Proteins 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
229930040373 Paraformaldehyde Natural products 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
241000288906 Primates Species 0.000 description 3
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 3
230000005867 T cell response Effects 0.000 description 3
230000009471 action Effects 0.000 description 3
239000013543 active substance Substances 0.000 description 3
229910052782 aluminium Inorganic materials 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
235000016520 artichoke thistle Nutrition 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
230000001588 bifunctional effect Effects 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
239000011616 biotin Substances 0.000 description 3
239000004202 carbamide Substances 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
210000002421 cell wall Anatomy 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
210000001947 dentate gyrus Anatomy 0.000 description 3
230000008021 deposition Effects 0.000 description 3
238000002405 diagnostic procedure Methods 0.000 description 3
231100000673 dose–response relationship Toxicity 0.000 description 3
239000012636 effector Substances 0.000 description 3
239000004744 fabric Substances 0.000 description 3
230000007387 gliosis Effects 0.000 description 3
230000001744 histochemical effect Effects 0.000 description 3
102000046783 human APP Human genes 0.000 description 3
230000002055 immunohistochemical effect Effects 0.000 description 3
230000002757 inflammatory effect Effects 0.000 description 3
238000007912 intraperitoneal administration Methods 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
210000004962 mammalian cell Anatomy 0.000 description 3
230000006984 memory degeneration Effects 0.000 description 3
208000023060 memory loss Diseases 0.000 description 3
239000003226 mitogen Substances 0.000 description 3
239000002052 molecular layer Substances 0.000 description 3
201000000050 myeloid neoplasm Diseases 0.000 description 3
229920002866 paraformaldehyde Polymers 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
102000013415 peroxidase activity proteins Human genes 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
239000012071 phase Substances 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
229920000747 poly(lactic acid) Polymers 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
230000002062 proliferating effect Effects 0.000 description 3
238000011321 prophylaxis Methods 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
150000007949 saponins Chemical class 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
210000004988 splenocyte Anatomy 0.000 description 3
238000003756 stirring Methods 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
239000000829 suppository Substances 0.000 description 3
238000004448 titration Methods 0.000 description 3
238000001890 transfection Methods 0.000 description 3
230000009466 transformation Effects 0.000 description 3
210000003934 vacuole Anatomy 0.000 description 3
239000013603 viral vector Substances 0.000 description 3
QPILHXCDZYWYLQ-UHFFFAOYSA-N 2-nonyl-1,3-dioxolane Chemical compound CCCCCCCCCC1OCCO1 QPILHXCDZYWYLQ-UHFFFAOYSA-N 0.000 description 2
244000298715 Actinidia chinensis Species 0.000 description 2
235000009434 Actinidia chinensis Nutrition 0.000 description 2
235000009436 Actinidia deliciosa Nutrition 0.000 description 2
108700028369 Alleles Proteins 0.000 description 2
241000193830 Bacillus <bacterium> Species 0.000 description 2
101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 description 2
108010047041 Complementarity Determining Regions Proteins 0.000 description 2
241000700626 Cowpox virus Species 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
241000700662 Fowlpox virus Species 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
101100268553 Homo sapiens APP gene Proteins 0.000 description 2
101000851593 Homo sapiens Separin Proteins 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
101000962498 Macropis fulvipes Macropin Proteins 0.000 description 2
101710161955 Mannitol-specific phosphotransferase enzyme IIA component Proteins 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
108091028043 Nucleic acid sequence Proteins 0.000 description 2
101100491259 Oryza sativa subsp. japonica AP2-2 gene Proteins 0.000 description 2
235000019483 Peanut oil Nutrition 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
102100036750 Separin Human genes 0.000 description 2
229920002684 Sepharose Polymers 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 2
239000007997 Tricine buffer Substances 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
241000711975 Vesicular stomatitis virus Species 0.000 description 2
230000001594 aberrant effect Effects 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
210000003567 ascitic fluid Anatomy 0.000 description 2
239000011324 bead Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
238000010382 chemical cross-linking Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000010835 comparative analysis Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
239000013068 control sample Substances 0.000 description 2
230000037029 cross reaction Effects 0.000 description 2
NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
230000005786 degenerative changes Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
238000004945 emulsification Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
239000000284 extract Substances 0.000 description 2
210000005153 frontal cortex Anatomy 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
230000012010 growth Effects 0.000 description 2
230000002489 hematologic effect Effects 0.000 description 2
239000012456 homogeneous solution Substances 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
210000004754 hybrid cell Anatomy 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
230000003308 immunostimulating effect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
230000010354 integration Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000010255 intramuscular injection Methods 0.000 description 2
239000007927 intramuscular injection Substances 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000004816 latex Substances 0.000 description 2
229920000126 latex Polymers 0.000 description 2
230000003902 lesion Effects 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
239000003446 ligand Substances 0.000 description 2
230000031700 light absorption Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
238000011068 loading method Methods 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000001589 lymphoproliferative effect Effects 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
239000000693 micelle Substances 0.000 description 2
244000000010 microbial pathogen Species 0.000 description 2
230000007388 microgliosis Effects 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
239000004005 microsphere Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
229940126619 mouse monoclonal antibody Drugs 0.000 description 2
210000002682 neurofibrillary tangle Anatomy 0.000 description 2
230000002981 neuropathic effect Effects 0.000 description 2
230000007171 neuropathology Effects 0.000 description 2
210000004179 neuropil Anatomy 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
210000000287 oocyte Anatomy 0.000 description 2
230000000242 pagocytic effect Effects 0.000 description 2
230000005298 paramagnetic effect Effects 0.000 description 2
239000000312 peanut oil Substances 0.000 description 2
238000010647 peptide synthesis reaction Methods 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
239000002243 precursor Substances 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
239000001397 quillaja saponaria molina bark Substances 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
230000007342 reactive astrogliosis Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
229930182490 saponin Natural products 0.000 description 2
230000007017 scission Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000013049 sediment Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000035939 shock Effects 0.000 description 2
210000003625 skull Anatomy 0.000 description 2
241000894007 species Species 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000000758 substrate Substances 0.000 description 2
229960002317 succinimide Drugs 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
108010026424 tau Proteins Proteins 0.000 description 2
102000013498 tau Proteins Human genes 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000002110 toxicologic effect Effects 0.000 description 2
231100000027 toxicology Toxicity 0.000 description 2
231100000041 toxicology testing Toxicity 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
230000001131 transforming effect Effects 0.000 description 2
XETCRXVKJHBPMK-MJSODCSWSA-N trehalose 6,6'-dimycolate Chemical compound C([C@@H]1[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C(CCCCCCCCCCC3C(C3)CCCCCCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)O2)O)O1)O)OC(=O)C(C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)CCCCCCCCCCC1CC1CCCCCCCCCCCCCCCCCC XETCRXVKJHBPMK-MJSODCSWSA-N 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
239000004474 valine Substances 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 1
NGEZPLCPKXKLQQ-VOTSOKGWSA-N (e)-4-(3-methoxyphenyl)but-3-en-2-one Chemical compound COC1=CC=CC(\C=C\C(C)=O)=C1 NGEZPLCPKXKLQQ-VOTSOKGWSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
QDSAUUOUBPKTKQ-UHFFFAOYSA-N 2-(2,4-dihydroxyphenyl)-4,5,7-trihydroxy-4H-chromen-3-one Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(=O)C1C1=CC=C(O)C=C1O QDSAUUOUBPKTKQ-UHFFFAOYSA-N 0.000 description 1
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
PMJHNEFCWLUZBC-UHFFFAOYSA-N 4-(4-amino-3-methylphenyl)-2,6,6-trimethylcyclohexa-1,3-dien-1-amine Chemical compound CC1=C(N)C(C)(C)CC(C=2C=C(C)C(N)=CC=2)=C1 PMJHNEFCWLUZBC-UHFFFAOYSA-N 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
101800000263 Acidic protein Proteins 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
240000000489 Agave utahensis Species 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
240000000662 Anethum graveolens Species 0.000 description 1
108010032595 Antibody Binding Sites Proteins 0.000 description 1
108010060159 Apolipoprotein E4 Proteins 0.000 description 1
108010039627 Aprotinin Proteins 0.000 description 1
240000003291 Armoracia rusticana Species 0.000 description 1
235000011330 Armoracia rusticana Nutrition 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
230000003844 B-cell-activation Effects 0.000 description 1
231100000699 Bacterial toxin Toxicity 0.000 description 1
206010004950 Birth mark Diseases 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
101800001415 Bri23 peptide Proteins 0.000 description 1
101800000655 C-terminal peptide Proteins 0.000 description 1
102400000107 C-terminal peptide Human genes 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
206010015548 Euthanasia Diseases 0.000 description 1
241000237858 Gastropoda Species 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
102000053171 Glial Fibrillary Acidic Human genes 0.000 description 1
101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
206010018498 Goitre Diseases 0.000 description 1
241000581652 Hagenia abyssinica Species 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
244000084296 Hernandia moerenhoutiana Species 0.000 description 1
235000010044 Hernandia moerenhoutiana Nutrition 0.000 description 1
102100028895 Heterogeneous nuclear ribonucleoprotein M Human genes 0.000 description 1
229920000209 Hexadimethrine bromide Polymers 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101000839073 Homo sapiens Heterogeneous nuclear ribonucleoprotein M Proteins 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
208000035150 Hypercholesterolemia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
102000008192 Lactoglobulins Human genes 0.000 description 1
108010060630 Lactoglobulins Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
102100039564 Leukosialin Human genes 0.000 description 1
108010005832 Leukosialin Proteins 0.000 description 1
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
101710093519 Microtubule-associated protein 4 Proteins 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
101001129925 Mus musculus Leptin receptor Proteins 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
240000002834 Paulownia tomentosa Species 0.000 description 1
235000010678 Paulownia tomentosa Nutrition 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
108010020346 Polyglutamic Acid Proteins 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241001620634 Roger Species 0.000 description 1
WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
241000235342 Saccharomycetes Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
206010039966 Senile dementia Diseases 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
VDRMSHBDXWSTNR-UHFFFAOYSA-N [Na].NC(=N)N Chemical compound [Na].NC(=N)N VDRMSHBDXWSTNR-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
210000001642 activated microglia Anatomy 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
230000000240 adjuvant effect Effects 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
230000032683 aging Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
229940037003 alum Drugs 0.000 description 1
DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
229940024546 aluminum hydroxide gel Drugs 0.000 description 1
SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
239000003708 ampul Substances 0.000 description 1
206010002022 amyloidosis Diseases 0.000 description 1
230000002547 anomalous effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
101150031224 app gene Proteins 0.000 description 1
229960004405 aprotinin Drugs 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
150000001491 aromatic compounds Chemical class 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
108010030694 avidin-horseradish peroxidase complex Proteins 0.000 description 1
230000003376 axonal effect Effects 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
239000000688 bacterial toxin Substances 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
230000006399 behavior Effects 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
150000001557 benzodiazepines Chemical class 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000002051 biphasic effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
239000012503 blood component Substances 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
238000009583 bone marrow aspiration Methods 0.000 description 1
229910021538 borax Inorganic materials 0.000 description 1
KDPAWGWELVVRCH-UHFFFAOYSA-N bromoacetic acid Chemical compound OC(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-N 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
210000005056 cell body Anatomy 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
210000004720 cerebrum Anatomy 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000009137 competitive binding Effects 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
201000003740 cowpox Diseases 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
239000002577 cryoprotective agent Substances 0.000 description 1
210000005220 cytoplasmic tail Anatomy 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000005034 decoration Methods 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000001934 delay Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
239000002274 desiccant Substances 0.000 description 1
239000003599 detergent Substances 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000003113 dilution method Methods 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
210000005110 dorsal hippocampus Anatomy 0.000 description 1
238000001647 drug administration Methods 0.000 description 1
239000000975 dye Substances 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000003979 eosinophil Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000005284 excitation Effects 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
238000013213 extrapolation Methods 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
230000003619 fibrillary effect Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000006870 function Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
150000002333 glycines Chemical class 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
201000003872 goiter Diseases 0.000 description 1
210000002149 gonad Anatomy 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000004326 gyrus cinguli Anatomy 0.000 description 1
238000011597 hartley guinea pig Methods 0.000 description 1
210000003128 head Anatomy 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
239000000185 hemagglutinin Substances 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
108060003552 hemocyanin Proteins 0.000 description 1
206010019692 hepatic necrosis Diseases 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
150000002391 heterocyclic compounds Chemical class 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000001632 homeopathic effect Effects 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
229940124452 immunizing agent Drugs 0.000 description 1
229960001438 immunostimulant agent Drugs 0.000 description 1
239000003022 immunostimulating agent Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000015788 innate immune response Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
229960002725 isoflurane Drugs 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
229960000448 lactic acid Drugs 0.000 description 1
239000008101 lactose Substances 0.000 description 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
108010052968 leupeptin Proteins 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
238000004811 liquid chromatography Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
231100000149 liver necrosis Toxicity 0.000 description 1
230000004807 localization Effects 0.000 description 1
239000003509 long acting drug Substances 0.000 description 1
PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000003550 marker Substances 0.000 description 1
235000019988 mead Nutrition 0.000 description 1
238000002483 medication Methods 0.000 description 1
230000004630 mental health Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
210000001872 metatarsal bone Anatomy 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
JMUHBNWAORSSBD-WKYWBUFDSA-N mifamurtide Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O JMUHBNWAORSSBD-WKYWBUFDSA-N 0.000 description 1
229960005225 mifamurtide Drugs 0.000 description 1
208000027061 mild cognitive impairment Diseases 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
230000004660 morphological change Effects 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
230000000626 neurodegenerative effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
230000003961 neuronal insult Effects 0.000 description 1
230000007121 neuropathological change Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
210000001331 nose Anatomy 0.000 description 1
238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
210000004681 ovum Anatomy 0.000 description 1
229940094443 oxytocics prostaglandins Drugs 0.000 description 1
239000006179 pH buffering agent Substances 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
LUYQYZLEHLTPBH-UHFFFAOYSA-N perfluorobutanesulfonyl fluoride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O LUYQYZLEHLTPBH-UHFFFAOYSA-N 0.000 description 1
208000008494 pericarditis Diseases 0.000 description 1
206010034674 peritonitis Diseases 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
229940067631 phospholipid Drugs 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229920002643 polyglutamic acid Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000037452 priming Effects 0.000 description 1
208000037821 progressive disease Diseases 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000009696 proliferative response Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
230000000541 pulsatile effect Effects 0.000 description 1
210000003314 quadriceps muscle Anatomy 0.000 description 1
238000011158 quantitative evaluation Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
239000012679 serum free medium Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
235000010339 sodium tetraborate Nutrition 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000011285 therapeutic regimen Methods 0.000 description 1
150000007970 thio esters Chemical class 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
238000011820 transgenic animal model Methods 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
230000032258 transport Effects 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
230000008728 vascular permeability Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000002569 water oil cream Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1